By Labiotech –
This week on the podcast, we have a conversation with Dr Paul Song, CEO of NKGen Biotech, a company with its sights set on changing the Alzheimer’s disease treatment landscape with natural killer cells.
The company’s natural killer (NK) cell Alzheimer’s treatment uses a patient’s cells, collected by a simple blood draw. The cells are then enhanced in a lab and then infused back into the patient’s body (with little to no side effects).
NKGen is also tackling cancer, and the company’s platform has the capacity to take on other diseases.
